baber/WOPTO huggingface dataset:
Patent AU-2002315392-B2 (AU)
Title: Liver engrafting cells, assays, and uses thereof
Inventor: AUSTIN TIMOTHY
IPC: A61P31/14
Filed: 2002-06-21
Granted: 2008-01-24
Abstract: A substantially enriched mammalian hepatic liver engrafting cell population is provided. Methods are provided for the isolation and culture of this liver engrafting cell. The progenitor cells are obtained from a variety of sources, including fetal and adult tissues. The cells are useful in transplantation, for experimental evaluation, and as a source of lineage and cell specific products, including mRNA species useful in identifying genes specifically expressed in these cells, and as targets for the discovery of factors or molecules that can affect them.
Patent AU-2002319524-B2 (AU)
Title: A fusion protein
Inventor: TOPLEY NICHOLAS
IPC: C12N15/62
Filed: 2002-08-02
Granted: 2006-10-12
Abstract: The present invention relates to a fusion protein comprising a functional IL-6 molecule and a functional DS-sIL-6R molecule. The present invention also relates to a nucleic acid encoding the fusion protein, methods of producing the fusion protein, and the use of the fusion protein in the treatment of infectious diseases and in inflammatory and immunological disorders.
Patent AU-2003271287-B2 (AU)
Title: Paint roller support
Inventor: MARTIN BORJ A
IPC: B05C17/02
Filed: 2003-12-19
Granted: 2005-11-24
Abstract: Embodiments of a paint roller support for rotatably supporting a conventional paint roller cover are disclosed. In one embodiment, a paint roller support comprises a frame having an elongated shaft and at least one hub rotatably coupled to the shaft for supporting a conventional roller cover. A locking spring exerts a retaining force against an inner surface of the roller cover for frictionally retaining the roller cover on the hub while the paint roller support is used to deliver paint to a surface. Embodiments of a method for manufacturing a paint roller support also are disclosed.
Patent AU-2003279267-B2 (AU)
Title: Method of escalator modernization
Inventor: NURNBERG THOMAS
IPC: B66B23/00
Filed: 2003-10-14
Granted: 2008-02-14
Abstract: A method of modernizing an escalator using modular components. The mechanical and electrical parts of an existing escalator are removed, leaving only the structural truss framework and cross members as well as all external parts, such as external panels, that interface with the building. A single module is placed at the top of the escalator and another module at the bottom. A plurality of incline modules are placed in the central inclined part of the escalator, at each cross member. By utilizing these modules, the assembly of the escalator is simplified. Furthermore, an entirely new escalator system using the latest technology may be installed rather than merely installing new parts in an old system.
Patent AU-2004228416-B2 (AU)
Title: Imidazopyridine derivatives as melanocortin receptor agonists or antagonists
Inventor: POITOUT LYDIE
IPC: C07D471/04
Filed: 2004-03-29
Granted: 2010-02-11
Abstract: Derivatives of imidazopyridine which have a good affinity for certain sub-types of melanocortin receptors, in particular MC4 receptors and are useful for treating pathological states and diseases in which one or more melanocortin receptors are involved and pharmaceutical compositions containing said products.
Patent AU-2004291030-B2 (AU)
Title: Preventative effects of morinda citrifolia on mammary breast cancer
Inventor: WANG MIAN-YING
IPC: A61K/
Filed: 2004-08-11
Granted: 2007-09-20
Abstract: The present invention features a novel use of processed ingredients from the Indian mulberry plant. More specifically, the present invention features a novel use of processed Morinda citrifolia, namely Morinda citrifolia fruit juice, puree, or puree juice for treating breast cancer, and particularly for inhibiting and/or preventing the metastasis of carcinogenic cells within the mammary region of the breast, as well as destroying metastasized mammary or breast cancer cells. The present invention comprises the consumption of food products or medicinal products or compositions comprising processed Morinda citrifolia, in either puree or fruit juice form. The present invention also features a method of inhibiting carcinogen-mediated conversion of mammary cells and protecting DNA against carcinogen-mediated damage by administering a composition comprising water soluble Morinda citrifolia.
Patent AU-2005304075-B2 (AU)
Title: Clear, two-phase, foam-forming aerosol hairstyling product
Inventor: MOENKS MONIKA
IPC: A61K8/60
Filed: 2005-10-19
Granted: 2011-02-17
Abstract: A hair care product is described, which consists of transparent, pressure-resistant aerosol packaging, a device for foaming a composition contained in the aerosol packaging, and a foaming composition of at least two clear liquid phases separated from each other. The composition contains water; at least 15 wt %, based on the composition without aerosol propellant, water-soluble, liquid alcohol; at least one polymer, selected from hair-conditioning, hair-setting, and film-forming polymers; at least one hair-conditioning cationic surfactant; at least one foam-forming or foam-stabilizing surfactant, selected from nonionic surfactants with an HLB value of at least 10 and zwitterionic surfactants; as well as one water-insoluble, liquified aerosol propellant.
Patent AU-2006203531-B2 (AU)
Title: Financial products
Inventor: MCALARY MICHAEL
IPC: G06Q30/00
Filed: 2006-08-16
Granted: 2011-10-20
Abstract: C:WNRPortblDCC\JFS\37S44181 DOC-1909/2011 A method and apparatus for providing a financial product from a first party to a second party, wherein a processing system (10) is configured to receive loan parameters relating to 5 a loan from the first party to the second party; and, determine, using the loan parameters and a repayment rule: payments to be paid by the second party to the first party, and an allocation defining: a first portion used for at least partially repaying the principal and/or interest on the loan; and, a second portion used for at least partially acquiring an investment for the second party. The method and apparatus also allows for the financial 10 product to be maintained. (Fig. 1)
Patent AU-2006237616-B2 (AU)
Title: Antibodies and related molecules that bind to PSCA proteins
Inventor: MORRISON ROBERT KENDALL
IPC: C07K16/30
Filed: 2006-02-15
Granted: 2012-03-22
Abstract: Antibodies and molecules derived therefrom that bind to novel PSCA protein, and variants thereof, are described wherein PSCA exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, PSCA provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The PSCA gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with PSCA can be used in active or passive immunization.
Patent AU-2006263797-B2 (AU)
Title: Epigenetic and genetic treatment method and system
Inventor: FRED ZACOUTO
IPC: C12N5/075
Filed: 2006-05-04
Granted: 2011-10-06
Abstract: The invention relates to an epigenetic and genetic treatment method and system. The invention can be used to rejuvenate an adult cell nucleus without passing through an embryonic stage and to obtain a tissue that is genetically-rejuvenated and autologous in relation to the original nucleus, comprising the temporary introduction of a nucleus into an enucleated oocyte (genetic rejuvenation), followed by oocyte extraction prior to cell division. The treated nucleus can then be introduced into an adult cytoplasm originating from the nucleus. In this way, cell divisions from the rejuvenated nucleus take place in an adult autologous cytoplasm and the resulting cells immediately take the form of adult, differentiated and functional cells. The rejuvenated autologous tissue thus created can then be grafted without rejection to the adult tissue of the organism from the treated nucleus. Throughout the inventive procedure, the treated cytoplasms and nuclei remain permanently in the adult state and no artificial cell differentiation is necessary. In this way, the invention is different from standard deep cloning in which the treated cells must return to the embryonic stage and which involves artificial cell differentiation. In addition, the tissues derived from standard cloning are not immunologically compatible with the original adult tissues from the treated nucleus since the cell division thereof takes place in the oocyte which represents a foreign cytoplasm to the nucleus. Moreover, standard cloning enables the creation of whole organisms unlike the inventive method and system which can only be used to treat a single tissue. The possible applications of the invention include, for example, the repair of necrotic tissues, such as a myocardial infarction, and damaged tissues, such as the retina (RMD), heart failure, renal failure, liver failure and osteoporosis, the treatment of cancers that occur with age, such as prostate cancer, rectal cancer, colon cancer, etc. The anodyne implantation of a small volume of autologous, rejuvenated, still-healthy cells from the affected organ should inhibit the aforementioned cancers and the metastases thereof.
Patent AU-2006273887-B2 (AU)
Title: Locatable and information sound device and method
Inventor: KEANE JAMES BRENDAN
IPC: G08B3/10
Filed: 2006-07-13
Granted: 2012-03-15
Abstract: A device is described to provide a localisable information signal. The device is adapted to emit sequentially a locating sound signal comprising broad band sound and an information sound signal comprising at least verbal information. A signal generated by such a device, a system incorporating a plurality of such devices, and a method of enabling an individual to orientate in an environment using such a system or signal are also described.
Patent AU-2006274884-B2 (AU)
Title: Indol-3-yl-carbonyl-piperidin and piperazin derivatives
Inventor: SCHNIDER PATRICK
IPC: C07D403/06
Filed: 2006-07-19
Granted: 2012-04-05
Abstract: The present invention relates to indol-3-yl-carbonyl-piperidin and piperazin derivatives which act as V1a receptor antagonists and which are represented by Formula (I) wherein the residues R to R are as defined herein. The invention further relates to pharmaceutical compositions containing such compounds, their use in medicaments against dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder, anxious and depressive disorders, and methods of preparation thereof.
Patent AU-2006331007-B2 (AU)
Title: Cosmetic w/o emulsions with inorganic sunscreen stabilized with conjugated linoleic acid
Inventor: DOBKOWSKI BRIAN JOHN
IPC: A61K8/893
Filed: 2006-12-14
Granted: 2010-01-28
Abstract: A cosmetic water-in-oil composition is provided which includes a water-in-oil emulsifying silicone surfactant, an ultrafine titanium dioxide and conjugated linoleic acid. The presence of conjugated linoleic acid stabilizes the composition against color degradation and also maintains an approximately steady viscosity.
Patent AU-2007219009-B2 (AU)
Title: The use of deferiprone and methods to treat and/or prevent Friedreich Ataxia resulting from intracellular mishandling of iron
Inventor: MUNNICH ARNOLD
IPC: A61K31/4196
Filed: 2007-02-21
Granted: 2012-12-20
Abstract: A therapeutically effective amount of deferiprone or deferasirox or physiologically acceptable salts thereof for the prevention, stabilization, treatment, or reversal of iron-induced FRDA disease in patients resulting from mitochondrial iron-induced damage to preferentially reduce the iron stores in the mitochondria. Also for the treatment of other conditions affecting the brain where a key element in the generation of the resultant pathology is the intracellular mishandling of iron.
Patent AU-2007229006-B2 (AU)
Title: A device for delivering medical treatment
Inventor: FIERENS JOOST J
IPC: A61M29/02
Filed: 2007-03-20
Granted: 2012-07-26
Abstract: The present invention provides a medical device for the delivery of treatment fluid to body vessels, having a distal (21) and a proximal (20) end, comprising a self-expanding, hollow tubular member (9) and a delivery catheter (10) suitable for deploying a self-expanding, tubular member (9), wherein the tubular member (9) is configured to expand radially to form a central part (11) flanked by two annular ridges, which creates, in situ, an annular lumen for that can apply treatment fluid locally to a vessel and a passageway that can maintain the flow of blood though the vessel. The device is particularly suited for minimally invasive and repeatable organ perfusion. It also relates to a method for organ perfusion.
Patent AU-2007238186-B2 (AU)
Title: Disheveled PDZ modulators
Inventor: COSTA MIKE
IPC: G01N33/50
Filed: 2007-04-09
Granted: 2014-01-09
Abstract: The invention provides modulators of Dvl PDZ-ligand interaction, and methods of identifying and using these modulators.
Patent AU-2007247964-B2 (AU)
Title: Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same
Inventor: LARSEN GUSTAVO
IPC: B05D7/00
Filed: 2007-05-03
Granted: 2012-01-19
Abstract: Capsules and particles with at least one encapsulated and/or entrapped agent, such as therapeutic agent, imaging agents, and other constituents may be produced by electrohydrodynamic processes. More particularly, the agent encapsulated in a vehicle, capsule, particle, vector, or carrier may maximize treatment and/or imaging of malignant cancers while minimizing the adverse effects of treatment and/or imaging.
Patent AU-2007270878-B2 (AU)
Title: Method of controlling an apparatus for generating electric power and apparatus for use in said method
Inventor: GEEST CLAUS
IPC: C10J3/20
Filed: 2007-06-29
Granted: 2012-01-19
Abstract: A method of controlling an apparatus for generating electric power and apparatus for use in said method, the apparatus comprising a gasifier for biomass material, such as waste, wood chips, straw, etc., said gasifier being of the shaft and updraft fixed bed type, which from the top is charged with the raw material for gasification and into the bottom of which gasifying agent is introduced, and a gas engine driving an electrical generator for producing electrical power, said gas engine being driven by the fuel gas from the gasifier. By supplying the produced fuel gas directly from the gasifier to the gas engine and controlling the production of the fuel gas in the gasifier in order to maintain a constant electrical output power, the necessity of using a gas holder between the gasifier and the gas engine is avoided.
Patent AU-2007271272-B2 (AU)
Title: Plasma separation membrane
Inventor: HORNUNG MARKUS
IPC: B01D71/28
Filed: 2007-06-25
Granted: 2010-10-14
Abstract: A process for manufacturing of an asymmetric hollow fibre membrane, comprising the steps of extruding a polymer solution through the outer ring slit of a hollow fibre spinning nozzle, simultaneously extruding a centre fluid through the inner bore of the hollow fibre spinning nozzle, into a precipitation bath, whereby the polymer solution contains 10 to 26 wt-% of polysulfone (PSU), polyethersulfone (PES) or polyarylethersulfone (PAES), 8 to 15 wt-% polyvinylpyrrolidone (PVP), 55 to 75 wt-% N-alkyl-2-pyrrolidone (NAP) and 3 to 9 wt-% water the centre fluid contains 70 to 90 wt-% N-alkyl-2-pyrrolidone (NAP) and 10 to 30 wt-% water, and the precipitation bath contains 0 to 20 wt-% N-alkyl-2-pyrrolidone (NAP) and 80 to 100 wt-% water.
Patent AU-2007283467-B2 (AU)
Title: Evaporator defrost cycle with concurrent refrigeration
Inventor: ISLAM RAFIQUL
IPC: F25D21/06
Filed: 2007-08-10
Granted: 2012-08-30
Abstract: An evaporator defrost system in a refrigeration system including an insulated refrigeration cabinet, the defrost system comprising: an evaporator within the cabinet having a refrigeration mode for cooling air and a defrost mode, control means for controlling the flow of high pressure liquid refrigerant gas to an inlet side of said evaporator, means for circulation of air through the evaporator to a product storage space within the cabinet, means associated with the evaporator to control suction pressure to a compressor via an outlet line from the evaporator, sensing means to determine when a refrigeration temperature has reached a predetermined level, the defrost system including; means for maintaining at least partial refrigeration during a defrost cycle.
Patent AU-2007285664-B2 (AU)
Title: Method for impregnating a porous body by a suspension and installation to use such a method.
Inventor: BRUNO CARTOIXA
IPC: B01J37/02
Filed: 2007-08-14
Granted: 2011-10-27
Abstract: The present invention relates to a process of impregnating a porous body (14) by a suspension (12) containing at least one part of particles, said body comprising many channels (16) bound by porous walls (22) extending from one (18) of the faces to the other (20) faces of said body, a part of said channels being blocked against one of the faces and the other part of the channels being blocked against the other face. According to the invention, the method consists in: - making a suspension whose particle size distribution has Dv90/Dpores ratio of less than 0.25 and whose viscosity is such that said suspension is brought inside the walls by putting a portion of the particles on the surface of the pores of the walls; - placing one (18, 20) of the faces of the body (14) in communication with an area (30) containing the suspension; - adding the suspension to the body; - exerting a force on the suspension added so that said suspension crosses the walls - make a liquid pass through the walls.
Patent AU-2007285951-B2 (AU)
Title: Process for producing biopolymer nanoparticles
Inventor: BLOEMBERGEN STEVEN
IPC: B29C48/58
Filed: 2007-08-14
Granted: 2012-12-13
Abstract: A process for producing a biopolymer nanoparticles product is disclosed. In this process, biopolymer feedstock and a plasticizer are fed to a feed zone of an extruder having a screw configuration in which the feedstock is process using shear forces in the extruder, and a crosslinking agent is added to the extruder downstream of the feed zone. The biopolymer feedstock and plasticizer are preferably added separately to the feed zone. The screw configuration may include two or more steam seal sections. Shear forces in a first section of the extruder may be greater than shear forces in an adjacent second section of the extruder downstream of the first section. In a post reaction section located after a point in which the crosslinking reaction has been completed, water may be added to improve die performance.
Patent AU-2007295876-B2 (AU)
Title: Radiation curable embossed ink security devices for security documents.
Inventor: BATISTATOS ODISEA
IPC: B42D101/00
Filed: 2007-09-14
Granted: 2013-09-19
Abstract: A security document and a method of manufacturing a security document are provided in which a radiation curable ink (18) is applied to at least one side of a substrate (11 ) including at least one region of transparent plastics material forming a window or half-window area (16; 26). The ink is embossed while soft and cured with radiation (242) to form an embossed security device (19) within the window or half-window area including one or more of a diffractive structure, a lens structure or other security element having a relief structure.
Patent AU-2008209364-B2 (AU)
Title: Providing automated or manual guidance on dynamic patient positioning based on measured variables for ventilation control
Inventor: JOHNSON ROYCE W
IPC: A61M16/20
Filed: 2008-01-18
Granted: 2013-01-24
Abstract: Methods and systems that incorporate automated or manual control of ventilation and kinetic rotation therapy are provided. In one exemplary embodiment, an artificial ventilator is used to artificially ventilate one of the patient's lungs, the status of the artificially ventilated lung is determined by measuring one or more ventilation status measures, and one or more of the ventilation status measures is used to provide feedback for controlling the positioning of the patient. In some exemplary embodiments, the feedback is used for automated control of the positioning of the patient, while in other exemplary embodiments, the feedback is used as guidance for manual control of the positioning of the patient.
Patent AU-2008258857-B2 (AU)
Title: A device, charging unit and method of filling a borehole with an explosive material
Inventor: OUCHTERLONY FINN
IPC: F42D3/04
Filed: 2008-06-04
Granted: 2013-05-16
Abstract: A device for receiving an explosive material comprises a receptacle unit (103) for receiving the explosive material (110), and an anchoring unit (212), wherein the anchoring unit is arranged on an. outer surface of the receptacle unit, and wherein the anchoring unit is adapted to anchor the flexible receptacle unit in a borehole.
Patent AU-2008289440-B2 (AU)
Title: Methods of forming an ophthalmic lens precursor and a lens
Inventor: ENNS JOHN B
IPC: B29D11/00
Filed: 2008-08-21
Granted: 2012-05-17
Abstract: Methods for forming an ophthalmic lens precursor from a reactive mixture, on a substrate with an arcuate optical quality surface via a source of actinic radiation controllable to cure a definable portion of a volume of the reactive mixture, with at least a portion of one surface free-formed.
Patent AU-2008301237-B2 (AU)
Title: Adjustable pipe coupling assembly
Inventor: ESDAILE DOUGLAS ALAN
IPC: E04H17/14
Filed: 2008-09-19
Granted: 2013-12-05
Abstract: An adjustable pipe coupling assembly (10) has a first clamp (30), a second clamp (32), and means (38, 40, 44) for rotating the clamps independently about a first common axis shared by the clamps and extending vertically. The first clamp (30) includes a first pair of opposed ears (52, 54) spaced apart so as to allow a first pipe (16) to be located therebetween. Each one of the opposed ears (52, 54) has a hole (56, 58) formed therethrough. The pair of holes (56, 58) share a second common axis extending in a first horizontal plane and are adapted to receive first pivot means, such as a bolt (60), therethrough for engaging the first pipe (16). The first pipe (16) is, as a result, pivotable in a first vertical plane about the second common axis. The second clamp (32) includes a second pair of opposed ears (52, 54) spaced apart so as to allow a second pipe (18) to be located therebetween. Each one of the opposed ears has a hole (56, 58) formed threthrough. The pair of holes share a third common axis perpendicular to the second common axis and extending in a second horizontal plane, the pair of holes being adapted to receive second pivot means, such as a bolt (60), therethrough for engaging the second pipe (18). The second pipe (18) is, as a result, pivotable in a second vertical plane about the third common axis. The arrangement is such that, in use, the rotating means rotate the clamps so as to adjust the horizontal angle between the second and third common axes, and each of the first and second pivot means pivot their respective pipe so as to adjust the vertical angle between the first and second pipes.
Patent AU-2008308691-B2 (AU)
Title: Antisense modulation of fibroblast growth factor receptor 4 expression
Inventor: YU XING-XIAN
IPC: C07H21/04
Filed: 2008-10-01
Granted: 2013-11-07
Abstract: Antisense compounds, compositions and methods are provided for modulating the expression of fibroblast growth factor receptor 4 (FGFR4). The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 4. Methods of using these compounds for modulation of fibroblast growth factor receptor 4 expression and for treatment of diseases associated with expression of fibroblast growth factor receptor 4 are provided.